- Home :
Developing New Therapeutic Monoclonal Antibodies to neutralize Adenosine immunosuppressive pathway in tumour context
Based on the broad immuno-suppression and strong tumour promotion (proliferation and dissemination) exerted by Adenosine, therapeutic strategies aimed at inhibiting Adenosine are highly promising
08 September 2015 M24 meeting in München
Genewake organizes its The TumAdoR M24 meeting in München (Germany), on 9 and 10 September 2015. Program here.
26 February 2015 M18 meeting in Marseille
The TUMADOR consortium organizes its M18 meeting in Marseille, France on 26 and 27 February 2015. Program here.